Amedalin

Amedalin
Clinical data
ATC code None
Identifiers
CAS Number 22136-26-1 YesY
22232-73-1 (HCl)
PubChem (CID) 31075
ChemSpider 28832 YesY
UNII 2OWK6X9N16 YesY
KEGG D02891 N
ChEMBL CHEMBL2110769 N
Chemical and physical data
Formula C19H22N2O
Molar mass 294.3925 g/mol
3D model (Jmol) Interactive image
 NYesY (what is this?)  (verify)

Amedalin (UK-3540-1) is an antidepressant which was synthesized in the early 1970s, but was never marketed.[1][2] It is a selective norepinephrine reuptake inhibitor, with no significant effects on the reuptake of serotonin and dopamine, and no antihistamine or anticholinergic properties.[2][3]

See also

References

  1. David J. Triggle (1997). Dictionary of pharmacological agents. London: Chapman & Hall. ISBN 0-412-46630-9.
  2. 1 2 Canas-Rodriquez A, Leeming PR (1972). "N-Phenyl-2-indolinones and N-phenylindolines - New class of antidepressant agents". Journal of Medicinal Chemistry. 15 (7): 762–770. doi:10.1021/jm00277a017.
  3. Koe BK (December 1976). "Molecular geometry of inhibitors of the uptake of catecholamines and serotonin in synaptosomal preparations of rat brain". Journal of Pharmacology and Experimental Therapeutics. 199 (3): 649–661.
This article is issued from Wikipedia - version of the 11/23/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.